dc.contributor.author |
Chinnaswamy, Sreedhar
|
|
dc.contributor.author |
Bhushan, Anand
|
|
dc.contributor.author |
Behera, Amit K.
|
|
dc.contributor.author |
Ghosh, Sumona
|
|
dc.contributor.author |
Rampurkar, Vijay
|
|
dc.contributor.author |
Chandra, Vikas
|
|
dc.contributor.author |
Pandit, Bhaswati
|
|
dc.contributor.author |
Kundu, Tapas Kumar
|
|
dc.date.accessioned |
2017-01-24T06:20:42Z |
|
dc.date.available |
2017-01-24T06:20:42Z |
|
dc.date.issued |
2016 |
|
dc.identifier.citation |
Chinnaswamy, S.; Bhushan, A.; Behera, A. K.; Ghosh, S.; Rampurkar, V.; Chandra, V.; Pandit, B.; Kundu, T. K., Roles for Transcription Factors Sp1, NF-kappa B, IRF3, and IRF7 in Expression of the Human IFNL4 Gene. Viral Immunology 2016, 29 (1), 49-63 http://dx.doi.org/10.1089/vim.2015.0076 |
en_US |
dc.identifier.citation |
Viral Immunology |
en_US |
dc.identifier.citation |
29 |
en_US |
dc.identifier.citation |
1 |
en_US |
dc.identifier.issn |
0882-8245 |
|
dc.identifier.uri |
https://libjncir.jncasr.ac.in/xmlui/10572/2088 |
|
dc.description |
Restricted Access |
en_US |
dc.description.abstract |
The expression of a biologically active human IFN4 depends on the presence of a frameshift deletion polymorphism within the first exon of the interferon lambda 4 (IFNL4) gene. In this report, we use the lung carcinoma-derived cell line, A549, which is genetically viable to express a functional IFN4, to address transcriptional requirements of the IFNL4 gene. We show that the GC-rich DNA-binding transcription factor (TF) specificity protein 1 (Sp1) is recruited to the IFNL4 promoter and has a role in induction of gene expression upon stimulation with viral RNA mimic poly(I:C). By using RNAi and overexpression strategies, we also show key roles in IFNL4 gene expression for the virus-inducible TFs, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B), IFN regulatory factor 3 (IRF3), and IRF7. Interestingly, we also observe that overexpression of IFN4 influences IFNL4 promoter activity, which may further be dependent on the retinoic acid-inducible gene-I (RIG-I)-like receptor pathway. Together, our work for the first time reports on the functional characterization of the human IFNL4 promoter. |
en_US |
dc.description.uri |
1557-8976 |
en_US |
dc.description.uri |
http://dx.doi.org/10.1089/vim.2015.0076 |
en_US |
dc.language.iso |
English |
en_US |
dc.publisher |
Mary Ann Liebert, Inc |
en_US |
dc.rights |
@Mary Ann Liebert, Inc, 2016 |
en_US |
dc.subject |
Immunology |
en_US |
dc.subject |
Virology |
en_US |
dc.subject |
Interferon-Lambda Family |
en_US |
dc.subject |
Dependent Rna-Polymerase |
en_US |
dc.subject |
Hepatitis-C |
en_US |
dc.subject |
Immune-Response |
en_US |
dc.subject |
Betulinic Acid |
en_US |
dc.subject |
Virus-Rna |
en_US |
dc.subject |
Protein |
en_US |
dc.subject |
Infection |
en_US |
dc.subject |
Innate |
en_US |
dc.subject |
Polymorphisms |
en_US |
dc.title |
Roles for Transcription Factors Sp1, NF-kappa B, IRF3, and IRF7 in Expression of the Human IFNL4 Gene |
en_US |
dc.type |
Article |
en_US |